Drug recall · August 6, 2014
Benicar HCT Tablets recall
Why: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-105-30
- Lots / codes
Lot #0002106 Exp - 11/30/2016
- Quantity
- 108 bottles
- Company
- Daiichi Sankyo Pharma Development, Edison, NJ
- Distribution
- Nationwide
- Initiated
- July 12, 2014 · Voluntary: Firm initiated
- Classified
- July 31, 2014
- Reported
- August 6, 2014
- Ended
- March 16, 2015
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.